Paper · 55415

On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase.

Battula N and 1 other. J Biol Chem, 1976. Cited by 77 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase. Papers, record 55415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55415

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase.; PubMed
Journal: J Biol Chem; PubMed
Year: 1976; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/55415/; PubMed
The journal: https://conductscience.org/library/journal-index/2985121R; PubMed
Citations, by iCite: 77; iCite
Relative citation ratio, by iCite: 1.58; iCite
Revised in PubMed: 2021-02-10; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Battula N	N
2	Loeb LA	L A

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Avian Leukosis Virus	Major topic
Avian Myeloblastosis Virus	Major topic
DNA Replication	Major topic
Deoxyribonucleases	Major topic
Exonucleases	Major topic
RNA-Directed DNA Polymerase	Major topic
Base Sequence
Coliphages
DNA Nucleotidyltransferases
Escherichia coli
Molecular Weight
Pancreas
Species Specificity
Templates, Genetic

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMID	Title	Journal	Year	In Papers	Source
41,453,210	Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication.	FEMS Microbiol Rev	2026	https://conductscience.org/library/papers/41453210	PubMed
35,250,911	Enhanced Antiviral Ability by a Combination of Zidovudine and Short Hairpin RNA Targeting Avian Leukosis Virus.	Front Microbiol	2021	https://conductscience.org/library/papers/35250911	PubMed
24,277,178	The potential of nucleotide analogs as inhibitors of retroviruses and tumors.	Pharm Res	1984	https://conductscience.org/library/papers/24277178	PubMed
23,236,072	Estimating the rate of intersubtype recombination in early HIV-1 group M strains.	J Virol	2013	https://conductscience.org/library/papers/23236072	PubMed
18,599,104	Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.	Virology	2008	https://conductscience.org/library/papers/18599104	PubMed
12,388,687	Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.	J Virol	2002	https://conductscience.org/library/papers/12388687	PubMed
12,069,972	ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.	Antimicrob Agents Chemother	2002	https://conductscience.org/library/papers/12069972	PubMed
11,083,661	Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates.	Antimicrob Agents Chemother	2000	https://conductscience.org/library/papers/11083661	PubMed
9,811,824	Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.	Proc Natl Acad Sci U S A	1998	https://conductscience.org/library/papers/9811824	PubMed
9,488,471	Flexible positioning of the telomerase-associated nuclease leads to preferential elimination of nontelomeric DNA.	Mol Cell Biol	1998	https://conductscience.org/library/papers/9488471	PubMed

1 to 10 of 29

See all 29 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55415

GET https://conductscience.org/api/papers/v1/55415/cited_by?page=2

API reference For AI assistants